Company / SG&A per Share
Pacira BioSciences, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$7.97
FY2025
5-year range
$4.60 / $7.97
FY2021-FY2025
Trend
+25.4%
vs FY2024
Sector context
#20 of 210
Health Care
What the data says
Among 210 Health Care companies, Pacira BioSciences, Inc. is in the bottom 10% for sg&a per share. SG&A per Share has increased for 8 consecutive years, from $3.71 in FY2017 to $7.97 in FY2025.
Based on SEC 10-K filings.
7.97 in FY2025 with a 5-year CAGR of +13.5%. Top quartile in the Health Care sector.
Increased from $5.87 to $7.97 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +11.9%
- 5-Year CAGR
- +13.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 210This company $7.97 Sector average $29.50
▼
-73.0% below sector average
Key checks
Key Insights
- Pacira BioSciences, Inc.'s sg&a per share has grown for 8 consecutive years.
- In FY2025, sg&a per share increased 25.4% year-over-year.
- Ranks #20 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.97 | +25.4% |
| FY2024 | $6.36 | +8.4% |
| FY2023 | $5.87 | +3.1% |
| FY2022 | $5.69 | +23.7% |
| FY2021 | $4.60 | +8.8% |
| FY2020 | $4.23 | +8.0% |
| FY2019 | $3.92 | +4.4% |
| FY2018 | $3.75 | +1.2% |
| FY2017 | $3.71 | -10.4% |
| FY2016 | $4.14 | +7.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026